SG Americas Securities’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,100
Closed -$9K 3125
2025
Q1
$9K Hold
10,100
﹤0.01% 3411
2024
Q4
$2K Hold
10,100
﹤0.01% 3080
2024
Q3
$112K Hold
10,100
﹤0.01% 2970
2024
Q2
$187K Buy
+10,100
New +$5.34M ﹤0.01% 2200
2023
Q2
Sell
-15,000
Closed -$366K 2520
2023
Q1
$366K Buy
+15,000
New +$7.14M ﹤0.01% 1957
2022
Q4
Sell
-71,500
Closed -$473K 3140
2022
Q3
$473K Buy
+71,500
New +$34.2M 0.01% 1596
2021
Q1
Sell
-28,700
Closed -$44K 3351
2020
Q4
$44K Hold
28,700
﹤0.01% 3153
2020
Q3
$45K Hold
28,700
﹤0.01% 2531
2020
Q2
$135K Hold
28,700
﹤0.01% 3160
2020
Q1
$90K Sell
28,700
-83,200
-74% -$22.7M ﹤0.01% 3041
2019
Q4
$509K Buy
111,900
+8,700
+8% +$2.39M ﹤0.01% 1764
2019
Q3
$39K Hold
103,200
﹤0.01% 2844
2019
Q2
$777K Hold
103,200
0.01% 1595
2019
Q1
$1.15M Buy
+103,200
New +$29.8M 0.01% 1188
2015
Q1
Sell
-123,500
Closed -$877K 2663
2014
Q4
$877K Buy
+123,500
New +$15.3M ﹤0.01% 1300
2014
Q3
Sell
-10,000
Closed -$292K 2682
2014
Q2
$292K Hold
10,000
﹤0.01% 1869
2014
Q1
$221K Sell
10,000
-75,300
-88% -$6.81M ﹤0.01% 1891
2013
Q4
$1.19M Sell
85,300
-162,100
-66% -$14.4M ﹤0.01% 1137
2013
Q3
$1.29M Sell
247,400
-28,300
-10% -$2.43M 0.01% 1152
2013
Q2
$1.72M Buy
+275,700
New +$20.6M 0.01% 853

Other funds holding ELV

SG Americas Securities's ELV Position: Q1 2026 in Review

SG Americas Securities increased its Elevance Health (ELV) stake by 239% in Q1 2026, buying an estimated $184M and bringing the position to 796,553 shares worth $233M. The position accounts for 0.25% of the portfolio, ranked #59.

SG Americas Securities first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • SG Americas Securities held 796,553 shares of Elevance Health worth $233M as of Q1 2026.
  • SG Americas Securities bought 561,300 Elevance Health shares in Q1 2026, an estimated $184M.
  • Elevance Health made up 0.25% of SG Americas Securities's portfolio in Q1 2026, its #59 holding.
  • SG Americas Securities first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.